Clinical Trial: Pharmacokinetic, Safety and Efficacy Study of OMS201 in Subjects Undergoing Retrograde Ureteroscopic Removal of Upper Urinary Tract Stones

Sponsor and Collaborators
Omeros Corporation

Contact
Contact: Gregory Demopulos, M.D., CMO, CEO
206-676-5000

Principal Investigator
Elspeth McDougall, M.D.

ClinicalTrials.gov Identifier
NCT00857090